← All trials
NCT01181934
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2010
- Primary completion
- —
- Completion date
- Feb 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Johnson and JohnsonLead sponsor
- Agentschap NLCollaborator
- Janssen Pharmaceutica NVStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.